Angiodynamics (ANGO) Retained Earnings (2011 - 2026)
Angiodynamics' (ANGO) quarterly Retained Earnings came in at -$465.9 million in Q2 2026, down 22932.08% YoY from N/an in Q2 2025, and down 17318.74% on a QoQ basis from $2.7 million in Q1 2026.
Angiodynamics (ANGO) Retained Earnings (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Retained Earnings data on file, last reported at -$465.9 million in Q2 2026.
- Quarterly Retained Earnings fell 22932.08% year-over-year to -$465.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$465.9 million (down 22932.08% YoY) and the FY2026 annual result came in at -$465.9 million, down 22932.08% from the prior year.
- Retained Earnings retreated to -$465.9 million in Q2 2026, from $2.7 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $2.7 million in Q1 2026 to a low of -$465.9 million in Q2 2026.
- A 5-year average of -$123.1 million and a median of -$4.2 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings slumped 67267.71% — and 2025, when it soared 126.63%.
- Tracing ANGO's Retained Earnings over 5 years: stood at -$288000.0 in 2022, then tumbled by 67267.71% to -$194.0 million in 2023, then soared by 98.07% to -$3.7 million in 2024, then soared by 126.63% to $998000.0 in 2025, then tumbled by 46787.27% to -$465.9 million in 2026.
- The last three Retained Earnings figures came in at -$465.9 million (Q2 2026), $2.7 million (Q1 2026), and $998000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 133.50 Bn | 128.29 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.18 Bn | 51.32 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.16 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.56 Bn | 32.09 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 28.58 Bn | 25.90 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 24.94 Bn | 24.51 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.32 Bn | 14.91 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Angiodynamics | 653.00 Mn | 599.13 Mn | 46.77 Mn | -465.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -465.94 Mn |
| Feb 28, 2026 | 2.71 Mn |
| Nov 30, 2025 | 998,000.00 |
| Aug 31, 2025 | 61,000.00 |
| May 31, 2025 | -2.02 Mn |
| Feb 28, 2025 | -423.15 Mn |
| Nov 30, 2024 | -3.75 Mn |
| Aug 31, 2024 | -3.27 Mn |
| May 31, 2024 | -395.20 Mn |
| Feb 29, 2024 | -381.76 Mn |
| Nov 30, 2023 | -194.02 Mn |
| Aug 31, 2023 | -5.65 Mn |
| May 31, 2023 | -4.72 Mn |
| Feb 28, 2023 | -189.39 Mn |
| Nov 30, 2022 | -288,000.00 |
| Aug 31, 2022 | 807,000.00 |
| May 31, 2022 | 1.36 Mn |
| Feb 28, 2022 | -152.15 Mn |
| Nov 30, 2021 | 4.56 Mn |
| Aug 31, 2021 | 3.74 Mn |